Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Baidu Inc (ADR) (BIDU), Cognizant Technology Solutions Corp (CTSH), Valeant Pharmaceuticals Intl Inc (VRX): Stephen Mandel’s Top Three Stock Picks

Stephen Mandel’s Lone Pine Capital has revealed for the second quarter a portfolio of 67 companies worth $24.7 billion. The value of all holdings increased since the last quarter by $1.7 billion or 1.08%. Mandel’s portfolio is fairly diversified across individual stocks, but heavily focused on services and technology sectors, which together make more than 65% of all holdings.

 Michael Kors Lone Pine Capital

The top pick for the quarter is Baidu Inc (ADR) (NASDAQ:BIDU), the Chinese search giant, where the investor has acquired additional 1.1 million shares, increasing its stake to 8.9 million shares. The boosted stake has a market value of $1.6 billion and is making 6.74% of the portfolio. Lone Pine remains the largest shareholder in Baidu Inc (ADR) (NASDAQ:BIDU) from the hedge – funds tracked by insidermonkey.com.

Other investors in Baidu Inc (ADR) (NASDAQ:BIDU) include Andreas Halvorsen’s Viking Global with 4.6 million shares worth $874 million and William Von Mueffling’s Cantillon Capital Management with 2.3 million shares valued at $432 million.

On the second place in Mandel’s portfolio there is another information technology company, Cognizant Technology Solutions Corp (NASDAQ:CTSH), where the Greenwich, Connecticut-based hedge fund has 29 million shares, up by 3% since the last quarter. The stake in Cognizant Technology Solutions Corp (NASDAQ:CTSH) has a market value of $1.4 billion and makes 5.83% of the equity portfolio.

John Armitage’s Egerton Capital Limited is bullish on Cognizant Technology Solutions Corp (NASDAQ:CTSH) as well, having a stake of 6.4 million shares worth $316 million, as of the end of the second quarter.

On third place sits Valeant Pharmaceuticals Intl Inc (NYSE:VRX), the Canadian company involved in a high profile hostile takeover of its American counterpart Allergan, Inc. (NYSE:AGN). Mandel is an investor in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) since 2013 and bought additional 1.2 million shares in the past quarter.  The 10 million shares, which have a market value of $1.2 billion, represent 5.14% of the portfolio.

From the hedge funds we track, only two investors have a bigger stake in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) than Lone Pine. Jeffrey Ubben’s ValueAct Capital has 18.9 million shares worth 2.3 billion and Andreas Halvorsen’s Viking Global owns 11.8 million shares valued at $1.4 billion.

Lone Pine Capital, which was founded by Mandel in 1997, has returned 23% on average since inauguration by employing a bottom-up investment strategy.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!